SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036837
Filing Date
2020-08-05
Accepted
2020-08-05 16:21:00
Documents
76
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q flxn-10q_20200630.htm   iXBRL 10-Q 2965876
2 EX-31.1 flxn-ex311_6.htm EX-31.1 10133
3 EX-31.2 flxn-ex312_8.htm EX-31.2 10248
4 EX-32.1 flxn-ex321_10.htm EX-32.1 9144
  Complete submission text file 0001564590-20-036837.txt   10842361

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA flxn-20200630.xsd EX-101.SCH 61783
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flxn-20200630_cal.xml EX-101.CAL 61770
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flxn-20200630_def.xml EX-101.DEF 207726
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20200630_lab.xml EX-101.LAB 512103
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20200630_pre.xml EX-101.PRE 384881
10 EXTRACTED XBRL INSTANCE DOCUMENT flxn-10q_20200630_htm.xml XML 2253186
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36287 | Film No.: 201077624
SIC: 2834 Pharmaceutical Preparations